Announcing Six NEW ASH Clinical Practice Guidelines on VTE
Venous thromboembolism (VTE) is a highly prevalent and far-reaching public health problem that, despite effective new options for prevention…
Read Our News
Register Now for FWGBD’s Uterine Hemostasis Colloquium II
Uterine Hemostasis Colloquium II Preceding the HTRS/NASTH 2019 Scientific Symposium https://www.htrs.org/HTRS/Education-Events/HTRSNASTH-2019-Scientific-Sympoisum Program Co-Chairs: Andra H. James, MD, MPH, and Kenneth G. Mann, PhD Program Description:…
RFI from NHLBI: To Improve Treatment of Patients with the Severe Hemophilia A Phenotype
Soliciting Input for future research at the National Heart, Lung, and Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in patients with…
Improved Quality of Life for Adolescents with Heavy Menstrual Bleeding
What exactly is “quality of life”? To match objective measurements of menstrual bleeding and pair them with a rather subjective quality of life ideal, Tazim…
Grant Recipient Uses Mobile Device Observation in Sickle Cell Pain Study
Technology takes center stage in a new epidemiologic study of acute vaso-occlusive pain associated with menstruation in women with sickle cell disease (SCD). Deva Sharma,…
Our Grant Funds a Mission, at Once Global and Personal
When she began her medical training in India at Maulana Azad Medical College, Ruchika Sharma, MD noticed an alarming reality: “I saw a population of…
Collaboration Is Queen: Our Grant Fosters Interdisciplinary Medicine
Speaking with Julia Coleman, MD on the phone, you immediately get a vivid sense of her enthusiasm, one that doesn’t come through in email –…
Grant Opportunity: 2019 HTRS Mentored Research Award Program
The Hemostasis and Thrombosis Research Society’s Mentored Research Award Program (HTRS MRA) provides financial support for qualified fellows or junior attending/junior faculty pursuing clinical, translational, or basic…
NHLBI Announces Two New Funding Opportunities
The National Heart, Lung, and Blood Institute (NHLBI) has recently released two new Funding Opportunity Announcements (FOAs): Catalyzing Innovation in Late Phase Clinical Trial Design. The purpose…
New Directory for Women & Girls with Sickle Cell Disease
FWGBD is pleased to announce a new service map directory that shares information about the availability and range of services specifically devoted to the care…
Announcing the 2018 Promoting XXcellence in Women’s Health: Optimal Management of Women and Girls with Blood Disorders and Bleeding Disorders Award Winners
The Foundation for Women & Girls with Blood Disorders is pleased to announce the two winners of 2018 Promoting XXcellence in Women’s Health: Optimal Management of…
In Memory of Dr. Joan Cox Gill (6/23/43-5/9/18) A Force for Good in the Lives of So Many People
It is with great sadness that FWGBD shares the passing of Dr. Joan Cox Gill, a friend to the foundation and valued member of our…
FDA Approves Hydroxyurea Tablets for Pediatric Sickle Cell Anemia
On December 21, 2017, the U.S. Food and Drug Administration approved the use of hydroxyurea tablets in pediatric patients with sickle cell anemia to reduce…
An Interview with Dr. Andra James, MD, MPH
Recently ASH Clinical News interviewed Dr. Andra James, President of FWGBD's Board of Directors, about her career path. Click on the link below to hear…
NHLBI State-of-Science Workshop
This event has ended. For meeting updates, please revisit the website and follow NHLBI on Twitter: https://twitter.com/NHLBI_BLOODDir Factor VIII Inhibitors: Generating a National Blueprint for Future Research WHEN: May…